|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Recently approved and investigational antibiotics for treatment of severe infections caused by Gram positive bacteria显示文摘 | Appelbaum PC Jacobs MR | 2005 | Curr Opin Microbiol2005，8，5： | 1 |
| 2 | The Alexander pro- ject 1998-2000:susceptibility of pathogens isolated from community- acquired respiratory tract infection to commonly used antimicrohial a- gents 显示文摘 | Jaeobs MR Felmingham D Appelbaum PC | 2003 | J Antimicrob Chemother2003，52，2： | 1 |
| 3 | Two new mechanisms of macrolide resistance in clinical strains of Streptococcus pneumoniae from Eastern Europe and North America显示文摘 | T davies PC Appelbaum | 2000 | Antimicrob Agents Chemother2000，44，： | 1 |
| 4 | Postantibiotic effects of gatifloxacin against Gram-positive and negative organisms显示文摘 | Pankuch GA Jacobs MR Appelbaum PC | 1999 | Antimicrob Agents Chemother1999，43，12： | 1 |
| 5 | The Alexander project 1998-2000:susceptibility of pathogens isolated from community-acquired respiratory tract infection to com monly used antimicrobial agents显示文摘 | Jacobs MR Felmingham D Appelbaum PC | 2003 | J Antimicrob Chemother2003，52，2： | 1 |
| 6 | Multidrug-resistant streptococcus pneumoniae infections:current and future therapeutic options显示文摘 | van Bambeke F Reinert RR Appelbaum PC | 2007 | Drugs2007，67，16： | 1 |
| 7 | Resistance among Streptococcus pneumonias: Implications for drug selection 显示文摘 | Appelbaum PC | 2002 | Clin Infect Dis2002，34，： | 1 |
| 8 | The emergence of vancomycin-intermediate and vaneomycin-resistant Staphylococcus aureus 显示文摘 | Appelbaum PC | 2006 | Clin Microbiol Infect2006，12，1： | 1 |
| 9 | Susceptibilities of 177 penicillin susceptible and -resistant pneumococci to FK 037, cefpirome, cefepime, ceftriaxone, cefotaxirae, ceftazidime, imipenem, biapenem, meropenem, and vancomycin 显示文摘 | Spangler SK Jacobs MR Appelbaum PC | 1994 | Antimicrob Agents Chemother1994，38，4： | 1 |
| 10 | Susceptibilities of 540 anaerobic gram-negative bacilli to amoxicillin, amoxicillinBRL 42715, amoxicillin-clavulanate, temafloxacin, and clindamycin显示文摘 | Appelbaum PC Spangler SK Shiman R | 1992 | Antimicrob Agents Chemother1992，36，5： | 1 |
| 11 | Two new mechanisms of macrolide resistance in clinical strains of Streptococcus paneumoniae from Eastern Europe and Noah America 显示文摘 | Tait-Kamradt A Davies T Appelbaum PC et al | 2000 | Antimicrob Agents Chemother2000，44，33： | 1 |
| 12 | The fluoroquinolone antibacterial:past,present,and perspectives显示文摘 | Appelbaum PC Hunter PA | 2000 | Int J Antimicrob Agents2000，16，1： | 1 |
| 13 | Reduced glyeopeptides susceptibility in methicil-tin-resistant Staphylococcusaureus (MRSA)显示文摘 | Appelbaum PC | 2007 | Int J Antimicrob Agents2007，30，5： | 1 |
| 14 | The Alexander Pro - ject 1998-2000:susceptibility of pathogens isoland from community-acquired respiratory tract infection to commonly used antimicro- bial a - gents显示文摘 | Jaeobs MR Felmingham D Appelbaum PC | 2003 | J Antimicrob Chemother2003，52，： | 1 |
| 15 | The emergence of vancomyeinintermedi- ate and vancomycin-resistant Staphylococcus aureus显示文摘 | Appelbaum PC | 2006 | Clin Microbiol Infect2006，12，1： | 1 |
| 16 | Resistance among Streptococcus pneumoniae:Impli-cations for drug selection显示文摘 | Appelbaum PC | 2002 | Clin Infect Dis2002，34，12： | 1 |
| 17 | Postantlblotic effects of Trovafloxacin against gram - postive and -negative organisms显示文摘 | Pankuch GA J acobs MR Appelbaum PC | 1998 | Antimicrob Agents Chemother1998，42，6： | 1 |
| 18 | The emergence of vancomycin-intermediate andvancomycin-resistant Staphylococcus aureus 显示文摘 | Appelbaum PC | 2006 | Clin Microbiol Infect2006，12，1： | 1 |
| 19 | Two new mechanisms of macrolide resistance in clinical strains of Steptococcus pneumonlae from Eastern Europe and North America显示文摘 | Davies T Appelbaum PC et | 2000 | Antimicrob Agents Chemother2000，44，12： | 1 |
| 20 | The emergenee of vancomycin-intermediate and vaneomycin-resistant Staphylococcus aureus 显示文摘 | Appelbaum PC | 2006 | Clin Microbiol Infect2006，，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员